Product
Rapid Acting Insulin
1 clinical trial
3 indications
Indication
Corneal ulcerIndication
NTCUIndication
Diabetes MellitusClinical trial
Efficacy and Safety of Topical Insulin in Acute-onset Neurotrophic Keratopathy After Diabetic VitrectomyStatus: Not yet recruiting, Estimated PCD: 2023-08-01